HB0145            Pharmaceutical manufacturers-promotion of off label use.
Sponsored by: Clem
AN ACT relating to food and drugs; allowing pharmaceutical manufacturers to engage in truthful promotion of an off label use of a drug, biological product or device; specifying that truthful promotion of an off label use is not misbranding; disallowing action by a licensing board against a licensee solely for engaging in truthful promotion or prescribing of an off label use of a drug, biological product or device; specifying that this act does not require a health care insurer to cover the cost of off label use; specifying that the off label promotion or prescribing of a drug does not create a cause of action; providing definitions; and providing for an effective date.

[Top] [Back] [Home]